clenbuterol has been researched along with Disease Exacerbation in 2 studies
Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Clenbuterol, a beta-agonist, has plausible mechanisms for treating amyotrophic lateral sclerosis (ALS)." | 8.31 | Clenbuterol Treatment Is Safe and Associated With Slowed Disease Progression in a Small Open-Label Trial in Patients With Amyotrophic Lateral Sclerosis. ( Bedlack, R; Koeberl, DD; Li, X; Lutz, MW, 2023) |
| "Clenbuterol, a beta-agonist, has plausible mechanisms for treating amyotrophic lateral sclerosis (ALS)." | 4.31 | Clenbuterol Treatment Is Safe and Associated With Slowed Disease Progression in a Small Open-Label Trial in Patients With Amyotrophic Lateral Sclerosis. ( Bedlack, R; Koeberl, DD; Li, X; Lutz, MW, 2023) |
| "Treatment with clenbuterol, a beta(2)-adrenoceptor agonist that can enhance regeneration of motor neuron axons, opposed the development of motor deficits in parallel with a reduced proportion of motor neurons with eccentric nuclei consistent with improved synaptic function." | 1.32 | Clenbuterol retards loss of motor function in motor neuron degeneration mice. ( Etlinger, JD; Peng, H; Zeman, RJ, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, X | 1 |
| Koeberl, DD | 1 |
| Lutz, MW | 1 |
| Bedlack, R | 1 |
| Zeman, RJ | 1 |
| Peng, H | 1 |
| Etlinger, JD | 1 |
2 other studies available for clenbuterol and Disease Exacerbation
| Article | Year |
|---|---|
Clenbuterol Treatment Is Safe and Associated With Slowed Disease Progression in a Small Open-Label Trial in Patients With Amyotrophic Lateral Sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Clenbuterol; Disease Progression; Female; Hand Strength; Humans; Male | 2023 |
Clenbuterol retards loss of motor function in motor neuron degeneration mice.
Topics: Adrenergic beta-Agonists; Animals; Clenbuterol; Diagnostic Techniques, Neurological; Disease Models, | 2004 |